TRENTON, N.J. -- Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic ...
The battle over prescription data has been raging since 2006, and it is more than just another skirmish in the ongoing war over information privacy. The sanctity of the doctor-patient relationship is at stake.
How much influence should pharmaceutical companies have over doctors? The Supreme Court has agreed to review a Vermont law that prohibits the use of prescription data for marketing purposes.